Cardiovascular outcomes in adults with migraine treated with eptinezumab for migraine prevention: pooled data from four randomized, double-blind, placebo-controlled studies

Abstract Background Patients with migraine have an increased relative risk of cardio- and cerebrovascular events, and some migraine treatments may exacerbate this risk. The primary objective of this analysis was to determine whether the rate of cardiovascular adverse events was higher for patients w...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Timothy R. Smith, Egilius L. H. Spierings, Roger Cady, Joe Hirman, Anders Ettrup, Vivienne Shen
Format: article
Langue:EN
Publié: BMC 2021
Sujets:
R
Accès en ligne:https://doaj.org/article/86ab8c5590de45cab7f535c82db50e55
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!